Literature DB >> 16025153

Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML.

J Y Sun1, L Gaidulis, A Dagis, J Palmer, R Rodriguez, M M Miller, S J Forman, D Senitzer.   

Abstract

Killer Ig-like receptor (KIR) is a major cluster of the natural killer cell receptors and may play a role in the outcome of hematopoietic cell transplants. A total of 65 AML cases transplanted with T-replete hematopoietic cells from unrelated donors were retrospectively KIR-genotyped by a multiplex PCR method of our own design. The KIR gene frequency and genotype patterns in these 130 samples were consistent with the data in the literature. Based upon overall inhibitory and activating KIR genes in both donors and patients, we developed an algorithm to calculate a compatibility score for each transplant case as plus, zero or minus. Significantly higher incidence (18/20, 90%) of acute (a) GVHD (grade II-IV) was found in the transplant cases with plus scores than that (25/45, 56%) in the cases with zero or minus scores (P < 0.01). When the scores are sorted in the opposite way, fewer cases (13/26, 50%) of aGVHD were found in the transplants with minus scores than that (30/39, 77%) in the transplants with zero or plus scores (P < 0.05). The difference of aGVHD prevalence between the plus score and minus score groups is highly significant (P < 0.01). KIR genotype compatibility calculated by this algorithm may predict aGVHD incidence and be helpful in choosing donors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025153     DOI: 10.1038/sj.bmt.1705089

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  9 in total

1.  Analytical methods for disease association studies with immunogenetic data.

Authors:  Jill A Hollenbach; Steven J Mack; Glenys Thomson; Pierre-Antoine Gourraud
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Genetics of graft-versus-host disease: the major histocompatibility complex.

Authors:  Effie W Petersdorf
Journal:  Blood Rev       Date:  2012-11-20       Impact factor: 8.250

3.  Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.

Authors:  Heather J Symons; M Sue Leffell; Nancy D Rossiter; Marianna Zahurak; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-02       Impact factor: 5.742

4.  The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese people.

Authors:  Li Ping Dou; De Hua Zheng; Chang Wang; Jun Hua Liu; Jing Fen Sun; Hai Jie Jin; Chun Ji Gao; Li Yu; Wan Ming Da
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

5.  Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.

Authors:  Karina L McQueen; Kristel M Dorighi; Lisbeth A Guethlein; Ruby Wong; Bharati Sanjanwala; Peter Parham
Journal:  Hum Immunol       Date:  2007-03-12       Impact factor: 2.850

6.  The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation.

Authors:  John A Zaia; Joel Y Sun; Ghislaine M Gallez-Hawkins; Lia Thao; Arisa Oki; Simon F Lacey; Andrew Dagis; Joycelynne Palmer; Don J Diamond; Stephen J Forman; David Senitzer
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

Review 7.  Risk assessment in haematopoietic stem cell transplantation: histocompatibility.

Authors:  Effie W Petersdorf
Journal:  Best Pract Res Clin Haematol       Date:  2007-06       Impact factor: 3.020

Review 8.  Reduction of Relapse after Unrelated Donor Stem Cell Transplantation by KIR-Based Graft Selection.

Authors:  Silke Heidenreich; Nicolaus Kröger
Journal:  Front Immunol       Date:  2017-02-08       Impact factor: 7.561

Review 9.  Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation.

Authors:  Andrea Velardi; Loredana Ruggeri; Antonella Mancusi; Emanuela Burchielli; Katia Perruccio; Franco Aversa; Massimo F Martelli
Journal:  Semin Immunopathol       Date:  2008-11-11       Impact factor: 11.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.